TNDM Stock Price, Chart, Stats & News

Tandem Diabetes Care Inc
Save
1.03B
Market cap
–
Current P/E
1111.11x
Forward P/E
TNDM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 53.81% |
Operating margin | -18.18% |
Pretax margin | -19.74% |
Net margin | -20.17% |
Effective tax rate | -2.22% |
ROA | -23.23% |
ROE | -141.98% |
D/E | 3.64x |
Interest coverage ratio | -22.96x |
TNDM valuation
P/E | – |
P/S | 1.41x |
P/B | 9.20x |
P/CF | -146.91x |
P/FCF | -48.36x |
P/OCF | -146.91x |
PEG | 10.64x |
EV multiple | -5.51x |
About
Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities.
Similar securities
Based on sector and market capitalization
Report issue











